Related Experiment Videos
Ring-substituted quinolines as potential anti-tuberculosis agents.
Suryanarayana Vangapandu1, Meenakshi Jain, Rahul Jain
1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160 062, India.
Bioorganic & Medicinal Chemistry
|April 28, 2004
Summary
New quinoline compounds show potent antimycobacterial activity against drug-sensitive and resistant tuberculosis strains. These novel molecules demonstrate efficacy comparable to isoniazid, offering potential new treatments for tuberculosis.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Microbiology
Background:
- Tuberculosis remains a significant global health challenge, exacerbated by the rise of drug-resistant Mycobacterium tuberculosis strains.
- Existing anti-tuberculosis drugs face limitations due to resistance and side effects, necessitating the development of novel therapeutic agents.
Purpose of the Study:
- To synthesize and evaluate the in vitro antimycobacterial properties of a series of ring-substituted quinoline analogues against drug-sensitive and drug-resistant Mycobacterium tuberculosis H37Rv.
- To identify potent quinoline derivatives with minimal inhibitory concentrations (MIC) comparable to first-line anti-tuberculosis drugs.
Main Methods:
- Synthesis of 56 ring-substituted quinoline analogues across four series (1-4).
- In vitro susceptibility testing of synthesized compounds against drug-sensitive and single-drug-resistant (SDR) strains of Mycobacterium tuberculosis H37Rv.
- Determination of minimal inhibitory concentrations (MIC) for active compounds.
Main Results:
- Two compounds, 2h and 13g, demonstrated potent activity with an MIC of 1 microg/mL against drug-sensitive M. tuberculosis H37Rv, comparable to isoniazid.
- Selected analogues (2d, 2g, 2h, 4e, 6b, 13b, 13g, and 14e) exhibited MIC values less than or equal to 6.25 microg/mL.
- These selected compounds showed potent efficacy against SDR strains of M. tuberculosis H37Rv, with activity ranging from 6.25 to 50 microg/mL.
Conclusions:
- Ring-substituted quinolines represent a promising class of compounds for the development of new anti-tuberculosis agents.
- The identified potent analogues warrant further investigation for their therapeutic potential against both drug-sensitive and drug-resistant tuberculosis.
- The structure-activity relationship of these quinoline derivatives could guide the design of more effective anti-mycobacterial drugs.